Surgical treatment of intrahepatic cholangiocarcinoma based on the macroscopic subtype

Journal of Japanese Society of Gastroenterology

Volumn 109, Issue 11, 2012, Pages 1885-1894

  Ariizumi, Shun Ichi ^a   Yamamoto, Masakazu ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; CANCER SURGERY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; HUMANS;

EID: 84869756042     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Patel T : Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33; 1353-1357 : 2001
2. Shaib Y, El-Serag HB : The epidemiology of cholangiocarcinoma. Semin Liver Dis 24; 115-125 : 2004
3. Khan SA, Thomas HC, Davidson BR, et al : Cholangiocarcinoma. Lancet 366; 1303-1314 : 2005
4. Tomimatsu M, Ishiguro N, Taniai M, et al : Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 72; 683-688 : 1993
5. Songsivilai S, Dharakul T, Kanistanon D : Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand. Trans R Soc Trop Med Hyg 90; 505-507 : 1996
6. Yamamoto M, Takasaki K, Nakano M, et al : Minute nodular intrahepatic cholangiocarcinoma. Cancer 82; 2145-2149 : 1998
7. Shin HR, Lee CU, Park HJ, et al : Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer : a case-control study in Pusan, Korea. Int J Epidemiol 25; 933-940 : 1996
8. Donato F, Gelatti U, Tagger A, et al : Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis : a case-control study in Italy. Cancer Causes Control 12; 959-964 : 2001
9. Kobayashi M, Ikeda K, Saitoh S, et al : Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 88; 2471-2477 : 2000
10. Yamamoto S, Kubo S, Hai S, et al : Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 95; 592-595 : 2004
11. Shaib YH, El-Serag HB, Davila JA, et al : Risk factors of intrahepatic cholangiocarcinoma in the United States : a case-control study. Gastroenterology 128; 620-626 : 2005
12. Welzel TM, Graubard BI, El-Serag HB, et al : Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States : a population-based case-control study. Clin Gastroenterol Hepatol 5; 1221-1228 : 2007
13. Zhou YM, Yin ZF, Yang JM, et al : Risk factors for intrahepatic cholangiocarcinoma : a case-control study in China. World J Gastroenterol 14; 632-635 : 2008
14. Lee TY, Lee SS, Jung SW, et al : Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea : a case-control study. Am J Gastroenterol 103; 1716-1720 : 2008
15. Tao LY, He XD, Qu Q, et al : Risk factors for intrahepatic and extrahepatic cholangiocarcinoma : a case-control study in China. Liver Int 30; 215-221 : 2010
16. El-Serag HB, Engels EA, Landgren O, et al : Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection : A population-based study of U.S. veterans. Hepatology 49; 116-123 : 2009
17. Lee CH, Chang CJ, Lin YJ, et al : Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer 100; 1765-1770 : 2009
18. Shen WF, Zhong W, Xu F, et al : Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol 15; 5976-5982 : 2009
19. Yamamoto M, Takasaki K, Yoshikawa T, et al : Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol 69; 162-167 : 1998
20. Yamasaki S : Intrahepatic cholangiocarcinoma : macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10; 288-291 : 2003
21. Lim JH : Cholangiocarcinoma : morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 181; 819-827 : 2003
22. Morimoto Y, Tanaka Y, Ito T, et al : Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10; 432-440 : 2003
23. Shimada K, Sano T, Sakamoto Y, et al : Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma : a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg 31; 2016-2022 : 2007
24. Paik KY, Jung JC, Heo JS, et al : What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 23; 766-770 : 2008
25. Shimada K, Sano T, Nara S, et al : Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery 145; 411-416 : 2009
26. Guglielmi A, Ruzzenente A, Campagnaro T, et al : Intrahepatic cholangiocarcinoma : prognostic factors after surgical resection. World J Surg 33; 1247-1254 : 2009
27. Uchiyama K, Yamamoto M, Yamaue H, et al : Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma : a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 18; 443-452 : 2011
28. Liver Cancer 9; 224-227 : 2003
29. Yamamoto M, Ariizumi S, Otsubo T, et al : Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma. J Surg Oncol 87; 80-83 : 2004
30. Aishima S, Kuroda Y, Nishihara Y, et al : Proposal of progression model for intrahepatic cholangiocarcinoma : clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol 31; 1059-1067 : 2007
31. Hui CK, Yuen MF, Tso WK, et al : Cholangiocarcinoma in liver cirrhosis. J Gastroenterol Hepatol 18; 337-341 : 2003
32. Chen TC, Nakanuma Y, Zen Y, et al : Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 34; 651-658 : 2001
33. Kim YI, Yu ES, Kim ST : Intraductal variant of peripheral cholangiocarcinoma of the liver with Clonorchis sinensis infection. Cancer 63; 1562-1566 : 1989
34. Jang KT, Hong SM, Lee KT, et al : Intraductal papillary neoplasm of the bile duct associated with Clonorchis sinensis infection. Virchows Arch 453; 589-598 : 2008
35. Itai Y, Araki T, Furui S, et al : Computed tomography of primary intrahepatic biliary malignancy. Radiology 147; 485-490 : 1983
36. Choi BI, Park JH, Kim YI, et al : Peripheral cholangiocarcinoma and clonorchiasis : CT findings. Radiology 169; 149-153 : 1988
37. Fan ZM, Yamashita Y, Harada M, et al : Intrahepatic cholangiocarcinoma : spin-echo and contrast-enhanced dynamic MR imaging. AJR Am J Roentgenol 161; 313-317 : 1993
38. Kim TK, Choi BI, Han JK, et al : Peripheral cholangiocarcinoma of the liver : two-phase spiral CT findings. Radiology 204; 539-543 : 1997
39. Zhang Y, Uchida M, Abe T, et al : Intrahepatic peripheral cholangiocarcinoma : comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr 23; 670-677 : 1999
40. Loyer EM, Chin H, DuBrow RA, et al : Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma : enhancement patterns with quadruple phase helical CT-a comparative study. Radiology 212; 866-875 : 1999
41. Kim SJ, Lee JM, Han JK, et al : Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol 189; 1428-1434 : 2007
42. Chen LD, Xu HX, Xie XY, et al : Enhancement patterns of intrahepatic cholangiocarcinoma : comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol 81; 881-889 : 2008
43. Rimola J, Forner A, Reig M, et al : Cholangiocarcinoma in cirrhosis : absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma Hepatology 50; 791-798 : 2009
44. Honda H, Onitsuka H, Yasumori K, et al : Intrahepatic peripheral cholangiocarcinoma : two-phased dynamic incremental CT and pathologic correlation. J Comput Assist Tomogr 17; 397-402 : 1993
45. Murakami T, Nakamura H, Tsuda K, et al : Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma : pathologic correlation study. J Magn Reson Imaging 5; 165-170 : 1995
46. Yoshida Y, Imai Y, Murakami T, et al : Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging 24; 66-68 : 1999
47. Ariizumi S, Kotera Y, Takahashi Y, et al : Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes. J Surg Oncol 104; 130-139 : 2011
48. Bosman FT, Carneiro F, Hruban RH, et al : WHO Classification of Tumours of the Digestive System, IARC, Lyon, 2010
49. Steiner PE, Higginson J : Cholangiolocellular carcinoma of the liver. Cancer 12; 753-759 : 1959
50. Komuta M, Spee B, Vander Borght S, et al : Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 47; 1544-1556 : 2008
51. Kozaka K, Sasaki M, Fujii T, et al : A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules : 'bile ductular carcinoma'. Histopathology 51; 390-400 : 2007
52. Nakanuma Y, Sato Y, Harada K, et al : Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol 2; 419-427 : 2010
53. Fukukura Y, Hamanoue M, Fujiyoshi F, et al : Cholangiolocellular carcinoma of the liver : CT and MR findings. J Comput Assist Tomogr 24; 809-812 : 2000
54. Motosugi U, Ichikawa T, Nakajima H, et al : Cholangiolocellular carcinoma of the liver : imaging findings. J Comput Assist Tomogr 33; 682-688 : 2009
55. Okabayashi T, Yamamoto J, Kosuge T, et al : A new staging system for mass-forming intrahepatic cholangiocarcinoma : analysis of preoperative and postoperative variables. Cancer 92; 2374-2383 : 2001
56. Suzuki S, Sakaguchi T, Yokoi Y, et al : Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg 26; 687-693 : 2002
57. Uenishi T, Yamazaki O, Yamamoto T, et al : Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 12; 479-483 : 2005
58. Nathan H, Aloia TA, Vauthey JN, et al : A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16; 14-22 : 2009
59. Yamamoto M, Takasaki K, Yoshikawa T : Lymph node metastasis in intrahepatic cholangiocarcinoma. Jpn J Clin Oncol 29; 147-150 : 1999
60. Uenishi T, Kubo S, Yamazaki O, et al : Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary. Pancreat Surg 15; 417-422 : 2008
61. Nozaki Y, Yamamoto M, Ikai I, et al : Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma. Cancer 83; 1923-1929 : 1998
62. Nakagawa T, Kamiyama T, Kurauchi N, et al : Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 29; 728-733 : 2005
63. Kim JY, Kim MH, Lee TY, et al : Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma : a prospective study compared with conventional imaging. Am J Gastroenterol 103; 1145-1151 : 2008
64. Grobmyer SR, Wang L, Gonen M, et al : Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 244; 260-264 : 2006
65. Imai K, Yamamoto M, Ariizumi S : Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion. Hepatogastroenterology 57; 1333-1336 : 2010
66. American Joint Committee on Cancer : AJCC cancer staging manual, Edge SB, ed, 7th edition, Springer, New York, 2009
67. Ebata T, Kamiya J, Nishio H, et al : The concept of perihilar cholangiocarcinoma is valid. Br J Surg 96; 926-934 : 2009
68. Shimizu K, Kotera Y, Aruga A, et al : Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 19; 171-178 : 2012
69. Valle J, Wasan H, Palmer DH, et al : Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362; 1273-1281 : 2010
70. Okusaka T, Nakachi K, Fukutomi A, et al : Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer : a comparative multicentre study in Japan. Br J Cancer 103; 469-474 : 2010
71. Sasaki T, Isayama H, Nakai Y, et al : Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 65; 1101-1107 : 2010